HEADER TRANSFERASE 25-APR-17 5VLO TITLE THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT COMPND 3 DELTA; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP RESIDUES 3-301; COMPND 6 SYNONYM: CAMK-II SUBUNIT DELTA; COMPND 7 EC: 2.7.11.17; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CAMK2D, CAMKD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, CAMKII, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.SOMOZA,A.G.VILLASENOR REVDAT 3 13-MAR-24 5VLO 1 REMARK REVDAT 2 27-SEP-17 5VLO 1 REMARK REVDAT 1 23-AUG-17 5VLO 0 JRNL AUTH T.J.SOMOZA,A.G.VILLASENOR JRNL TITL INHIBITORS OF CAMKII JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.38 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 38959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.915 REMARK 3 FREE R VALUE TEST SET COUNT : 1453 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.3934 - 3.5051 1.00 7771 146 0.1514 0.1912 REMARK 3 2 3.5051 - 2.7822 1.00 7654 150 0.1875 0.2136 REMARK 3 3 2.7822 - 2.4305 1.00 7608 152 0.2048 0.2672 REMARK 3 4 2.4305 - 2.2083 1.00 7613 152 0.2251 0.3078 REMARK 3 5 2.2083 - 2.0500 1.00 7567 146 0.2659 0.3000 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.221 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.043 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4907 REMARK 3 ANGLE : 0.518 6639 REMARK 3 CHIRALITY : 0.041 709 REMARK 3 PLANARITY : 0.004 848 REMARK 3 DIHEDRAL : 18.791 2921 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VLO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-APR-17. REMARK 100 THE DEPOSITION ID IS D_1000227604. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38959 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : 12.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CAMKII S3-K301, IN 20MM IMIDAZOLE PH REMARK 280 8.5, 0.3M SODIUM CHLORIDE, 5MM TCEP, WAS CONCENTRATED TO 36 MG/ REMARK 280 ML AND FLASH FROZEN IN LIQUID NITROGEN FOR LONG TERM STORAGE AT - REMARK 280 80 C IN 10 UL ALIQUOTS. THE PROTEIN WAS THAWED AND DILUTED DOWN REMARK 280 TO 12 MG/ML IN THE SAME BUFFER JUST PRIOR TO CRYSTALLIZATION REMARK 280 EXPERIMENTS. SITTING DROP VAPOR DIFFUSION DROPLETS WERE REMARK 280 ASSEMBLED WITH 250 NL OF 12 MG/ML CAMKII, 0.6 MM INHIBITOR AND REMARK 280 250 NL OF RESERVOIR SOLUTION 24% PEG 3350, 0.2 M AMMONIUM REMARK 280 TARTRATE, 0.1 M ARGININE. FLAT CRYSTAL PLATES (TYPICALLY 0.03 MM REMARK 280 X 0.2 MM X 0.4 MM IN SIZE) GREW IN 4-7 DAYS AT 20 C. A CRYSTAL REMARK 280 SEED SUSPENSION WAS PREPARED WITH TEN CRUSHED CRYSTALS COMBINED REMARK 280 INTO 100 UL OF RESERVOIR SOLUTION AND STORED AT -80 C. A THIRTY REMARK 280 FOLD SEED DILUTION WAS PREPARED IN THE SAME SOLUTION FOR REMARK 280 ADDITION TO PROTEIN DROPLETS IN A 1 TO 1 VOLUME RATIO TO ENHANCE REMARK 280 CRYSTALLIZATION OF DIFFICULT TO CRYSTALLIZE INHIBITORS., VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.77300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 HIS A 1 REMARK 465 MET A 2 REMARK 465 SER A 3 REMARK 465 THR A 4 REMARK 465 THR A 5 REMARK 465 THR A 6 REMARK 465 CYS A 7 REMARK 465 LYS A 22 REMARK 465 GLY A 23 REMARK 465 ALA A 24 REMARK 465 LYS A 301 REMARK 465 GLY B 0 REMARK 465 HIS B 1 REMARK 465 MET B 2 REMARK 465 SER B 3 REMARK 465 THR B 4 REMARK 465 THR B 5 REMARK 465 THR B 6 REMARK 465 LEU B 300 REMARK 465 LYS B 301 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 520 O HOH B 645 2.19 REMARK 500 OE2 GLU A 100 NZ LYS A 299 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG B 221 NE ARG B 221 CZ -0.079 REMARK 500 ARG B 221 CZ ARG B 221 NH1 -0.080 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 17 -148.32 -117.89 REMARK 500 ARG A 135 -7.68 73.72 REMARK 500 ASP A 136 50.11 -142.21 REMARK 500 ASP A 157 109.07 64.78 REMARK 500 ALA A 175 145.71 -170.47 REMARK 500 PHE A 233 78.08 -117.09 REMARK 500 LEU A 253 40.61 -98.38 REMARK 500 PHE B 17 -149.51 -127.51 REMARK 500 PRO B 35 -71.95 -56.93 REMARK 500 ARG B 135 -1.49 74.68 REMARK 500 ASP B 136 47.13 -144.81 REMARK 500 ASP B 157 99.60 64.06 REMARK 500 PHE B 233 79.94 -116.77 REMARK 500 LEU B 253 44.94 -91.20 REMARK 500 ASN B 256 109.90 -59.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9EJ A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DTT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9EJ B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DTT B 402 DBREF 5VLO A 3 301 UNP Q13557 KCC2D_HUMAN 3 301 DBREF 5VLO B 3 301 UNP Q13557 KCC2D_HUMAN 3 301 SEQADV 5VLO GLY A 0 UNP Q13557 EXPRESSION TAG SEQADV 5VLO HIS A 1 UNP Q13557 EXPRESSION TAG SEQADV 5VLO MET A 2 UNP Q13557 EXPRESSION TAG SEQADV 5VLO GLY B 0 UNP Q13557 EXPRESSION TAG SEQADV 5VLO HIS B 1 UNP Q13557 EXPRESSION TAG SEQADV 5VLO MET B 2 UNP Q13557 EXPRESSION TAG SEQRES 1 A 302 GLY HIS MET SER THR THR THR CYS THR ARG PHE THR ASP SEQRES 2 A 302 GLU TYR GLN LEU PHE GLU GLU LEU GLY LYS GLY ALA PHE SEQRES 3 A 302 SER VAL VAL ARG ARG CYS MET LYS ILE PRO THR GLY GLN SEQRES 4 A 302 GLU TYR ALA ALA LYS ILE ILE ASN THR LYS LYS LEU SER SEQRES 5 A 302 ALA ARG ASP HIS GLN LYS LEU GLU ARG GLU ALA ARG ILE SEQRES 6 A 302 CYS ARG LEU LEU LYS HIS PRO ASN ILE VAL ARG LEU HIS SEQRES 7 A 302 ASP SER ILE SER GLU GLU GLY PHE HIS TYR LEU VAL PHE SEQRES 8 A 302 ASP LEU VAL THR GLY GLY GLU LEU PHE GLU ASP ILE VAL SEQRES 9 A 302 ALA ARG GLU TYR TYR SER GLU ALA ASP ALA SER HIS CYS SEQRES 10 A 302 ILE GLN GLN ILE LEU GLU SER VAL ASN HIS CYS HIS LEU SEQRES 11 A 302 ASN GLY ILE VAL HIS ARG ASP LEU LYS PRO GLU ASN LEU SEQRES 12 A 302 LEU LEU ALA SER LYS SER LYS GLY ALA ALA VAL LYS LEU SEQRES 13 A 302 ALA ASP PHE GLY LEU ALA ILE GLU VAL GLN GLY ASP GLN SEQRES 14 A 302 GLN ALA TRP PHE GLY PHE ALA GLY THR PRO GLY TYR LEU SEQRES 15 A 302 SER PRO GLU VAL LEU ARG LYS ASP PRO TYR GLY LYS PRO SEQRES 16 A 302 VAL ASP MET TRP ALA CYS GLY VAL ILE LEU TYR ILE LEU SEQRES 17 A 302 LEU VAL GLY TYR PRO PRO PHE TRP ASP GLU ASP GLN HIS SEQRES 18 A 302 ARG LEU TYR GLN GLN ILE LYS ALA GLY ALA TYR ASP PHE SEQRES 19 A 302 PRO SER PRO GLU TRP ASP THR VAL THR PRO GLU ALA LYS SEQRES 20 A 302 ASP LEU ILE ASN LYS MET LEU THR ILE ASN PRO ALA LYS SEQRES 21 A 302 ARG ILE THR ALA SER GLU ALA LEU LYS HIS PRO TRP ILE SEQRES 22 A 302 CYS GLN ARG SER THR VAL ALA SER MET MET HIS ARG GLN SEQRES 23 A 302 GLU THR VAL ASP CYS LEU LYS LYS PHE ASN ALA ARG ARG SEQRES 24 A 302 LYS LEU LYS SEQRES 1 B 302 GLY HIS MET SER THR THR THR CYS THR ARG PHE THR ASP SEQRES 2 B 302 GLU TYR GLN LEU PHE GLU GLU LEU GLY LYS GLY ALA PHE SEQRES 3 B 302 SER VAL VAL ARG ARG CYS MET LYS ILE PRO THR GLY GLN SEQRES 4 B 302 GLU TYR ALA ALA LYS ILE ILE ASN THR LYS LYS LEU SER SEQRES 5 B 302 ALA ARG ASP HIS GLN LYS LEU GLU ARG GLU ALA ARG ILE SEQRES 6 B 302 CYS ARG LEU LEU LYS HIS PRO ASN ILE VAL ARG LEU HIS SEQRES 7 B 302 ASP SER ILE SER GLU GLU GLY PHE HIS TYR LEU VAL PHE SEQRES 8 B 302 ASP LEU VAL THR GLY GLY GLU LEU PHE GLU ASP ILE VAL SEQRES 9 B 302 ALA ARG GLU TYR TYR SER GLU ALA ASP ALA SER HIS CYS SEQRES 10 B 302 ILE GLN GLN ILE LEU GLU SER VAL ASN HIS CYS HIS LEU SEQRES 11 B 302 ASN GLY ILE VAL HIS ARG ASP LEU LYS PRO GLU ASN LEU SEQRES 12 B 302 LEU LEU ALA SER LYS SER LYS GLY ALA ALA VAL LYS LEU SEQRES 13 B 302 ALA ASP PHE GLY LEU ALA ILE GLU VAL GLN GLY ASP GLN SEQRES 14 B 302 GLN ALA TRP PHE GLY PHE ALA GLY THR PRO GLY TYR LEU SEQRES 15 B 302 SER PRO GLU VAL LEU ARG LYS ASP PRO TYR GLY LYS PRO SEQRES 16 B 302 VAL ASP MET TRP ALA CYS GLY VAL ILE LEU TYR ILE LEU SEQRES 17 B 302 LEU VAL GLY TYR PRO PRO PHE TRP ASP GLU ASP GLN HIS SEQRES 18 B 302 ARG LEU TYR GLN GLN ILE LYS ALA GLY ALA TYR ASP PHE SEQRES 19 B 302 PRO SER PRO GLU TRP ASP THR VAL THR PRO GLU ALA LYS SEQRES 20 B 302 ASP LEU ILE ASN LYS MET LEU THR ILE ASN PRO ALA LYS SEQRES 21 B 302 ARG ILE THR ALA SER GLU ALA LEU LYS HIS PRO TRP ILE SEQRES 22 B 302 CYS GLN ARG SER THR VAL ALA SER MET MET HIS ARG GLN SEQRES 23 B 302 GLU THR VAL ASP CYS LEU LYS LYS PHE ASN ALA ARG ARG SEQRES 24 B 302 LYS LEU LYS HET 9EJ A 401 39 HET DTT A 402 8 HET 9EJ B 401 39 HET DTT B 402 8 HETNAM 9EJ N-[(2S)-2-(DIETHYLAMINO)PROPYL]-2-[(2S)-2- HETNAM 2 9EJ (METHYLCARBAMOYL)AZETIDIN-1-YL]-6-[5-(THIOPHEN-2-YL) HETNAM 3 9EJ PYRAZOLO[1,5-A]PYRIMIDIN-3-YL]PYRIDINE-4-CARBOXAMIDE HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETSYN DTT 1,4-DITHIOTHREITOL FORMUL 3 9EJ 2(C28 H34 N8 O2 S) FORMUL 4 DTT 2(C4 H10 O2 S2) FORMUL 7 HOH *349(H2 O) HELIX 1 AA1 THR A 8 GLU A 13 1 6 HELIX 2 AA2 SER A 51 LEU A 68 1 18 HELIX 3 AA3 GLU A 97 VAL A 103 1 7 HELIX 4 AA4 SER A 109 ASN A 130 1 22 HELIX 5 AA5 LYS A 138 GLU A 140 5 3 HELIX 6 AA6 SER A 146 GLY A 150 5 5 HELIX 7 AA7 THR A 177 LEU A 181 5 5 HELIX 8 AA8 SER A 182 ARG A 187 1 6 HELIX 9 AA9 LYS A 193 GLY A 210 1 18 HELIX 10 AB1 ASP A 218 GLY A 229 1 12 HELIX 11 AB2 PRO A 236 VAL A 241 5 6 HELIX 12 AB3 THR A 242 LEU A 253 1 12 HELIX 13 AB4 THR A 262 LEU A 267 1 6 HELIX 14 AB5 HIS A 269 GLN A 274 1 6 HELIX 15 AB6 GLN A 274 ALA A 279 1 6 HELIX 16 AB7 ARG A 284 LYS A 299 1 16 HELIX 17 AB8 THR B 8 GLU B 13 1 6 HELIX 18 AB9 ASN B 46 LEU B 50 5 5 HELIX 19 AC1 SER B 51 LEU B 68 1 18 HELIX 20 AC2 GLU B 97 VAL B 103 1 7 HELIX 21 AC3 SER B 109 ASN B 130 1 22 HELIX 22 AC4 LYS B 138 GLU B 140 5 3 HELIX 23 AC5 THR B 177 LEU B 181 5 5 HELIX 24 AC6 SER B 182 ARG B 187 1 6 HELIX 25 AC7 LYS B 193 GLY B 210 1 18 HELIX 26 AC8 ASP B 218 ALA B 228 1 11 HELIX 27 AC9 THR B 242 LEU B 253 1 12 HELIX 28 AD1 THR B 262 LEU B 267 1 6 HELIX 29 AD2 HIS B 269 GLN B 274 1 6 HELIX 30 AD3 GLN B 274 ALA B 279 1 6 HELIX 31 AD4 ARG B 284 ARG B 298 1 15 SHEET 1 AA1 5 TYR A 14 GLY A 21 0 SHEET 2 AA1 5 VAL A 27 LYS A 33 -1 O VAL A 28 N LEU A 20 SHEET 3 AA1 5 GLU A 39 ASN A 46 -1 O TYR A 40 N CYS A 31 SHEET 4 AA1 5 PHE A 85 ASP A 91 -1 O PHE A 90 N ALA A 41 SHEET 5 AA1 5 LEU A 76 SER A 81 -1 N HIS A 77 O VAL A 89 SHEET 1 AA2 2 ILE A 132 VAL A 133 0 SHEET 2 AA2 2 ILE A 162 GLU A 163 -1 O ILE A 162 N VAL A 133 SHEET 1 AA3 2 LEU A 142 LEU A 144 0 SHEET 2 AA3 2 VAL A 153 LEU A 155 -1 O LYS A 154 N LEU A 143 SHEET 1 AA4 5 TYR B 14 LYS B 22 0 SHEET 2 AA4 5 VAL B 27 LYS B 33 -1 O VAL B 28 N LEU B 20 SHEET 3 AA4 5 GLU B 39 ILE B 45 -1 O ILE B 44 N VAL B 27 SHEET 4 AA4 5 PHE B 85 ASP B 91 -1 O PHE B 90 N ALA B 41 SHEET 5 AA4 5 LEU B 76 GLU B 82 -1 N HIS B 77 O VAL B 89 SHEET 1 AA5 2 ILE B 132 VAL B 133 0 SHEET 2 AA5 2 ILE B 162 GLU B 163 -1 O ILE B 162 N VAL B 133 SHEET 1 AA6 2 LEU B 142 LEU B 144 0 SHEET 2 AA6 2 VAL B 153 LEU B 155 -1 O LYS B 154 N LEU B 143 CISPEP 1 SER A 235 PRO A 236 0 3.24 CISPEP 2 SER B 235 PRO B 236 0 5.09 SITE 1 AC1 15 LEU A 20 GLY A 21 VAL A 28 ALA A 41 SITE 2 AC1 15 PHE A 90 ASP A 91 LEU A 92 VAL A 93 SITE 3 AC1 15 GLU A 140 ASN A 141 LEU A 143 ASP A 157 SITE 4 AC1 15 HOH A 543 HOH A 554 HOH A 566 SITE 1 AC2 7 GLN A 118 ILE A 272 CYS A 273 GLN A 274 SITE 2 AC2 7 ARG A 275 SER A 276 HOH A 661 SITE 1 AC3 16 LEU B 20 GLY B 21 LYS B 22 VAL B 28 SITE 2 AC3 16 ALA B 41 PHE B 90 ASP B 91 LEU B 92 SITE 3 AC3 16 VAL B 93 GLY B 96 GLU B 97 GLU B 140 SITE 4 AC3 16 ASN B 141 LEU B 143 ASP B 157 HOH B 553 SITE 1 AC4 6 GLN B 118 ILE B 272 CYS B 273 GLN B 274 SITE 2 AC4 6 ARG B 275 SER B 276 CRYST1 54.473 67.546 85.450 90.00 94.11 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018358 0.000000 0.001319 0.00000 SCALE2 0.000000 0.014805 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011733 0.00000